Robert Dean, MD, Oncology, Cleveland, OH, Cleveland Clinic

RobertMDeanMD

Oncology Cleveland, OH

Hematologic Oncology

Staff, Cleveland Clinic Taussig Cancer Institute | Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Dr. Dean is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dean's full profile

Already have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology/Oncology, 2000 - 2005
  • Boston University Medical Center
    Boston University Medical CenterFellowship, Hematology/Oncology, 1999 - 2000
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1996 - 1999
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1996

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2005 - 2023
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Publications & Presentations

PubMed

Abstracts/Posters

  • Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
    Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
    Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
    Robert M. Dean, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase I Trial of Carfilzomib + R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Impact of Clinical Versus Biochemical Progression on Post-Progression Survival in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Cleveland Clinic Cancer Doctor
    Cleveland Clinic Cancer DoctorNovember 13th, 2016

Professional Memberships

Hospital Affiliations